Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Preferred Dividend Payments (2021 - 2022)

Prime Medicine filings provide 2 years of Preferred Dividend Payments readings, the most recent being $1.3 million for Q4 2022.

  • On a quarterly basis, Preferred Dividend Payments rose 113.9% to $1.3 million in Q4 2022 year-over-year; TTM through Sep 2023 was $1.3 million, a 86.06% decrease, with the full-year FY2022 number at $20.2 million, up 1275.54% from a year prior.
  • Preferred Dividend Payments hit $1.3 million in Q4 2022 for Prime Medicine, down from $6.4 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $6.4 million in Q3 2022 to a low of -$9.5 million in Q4 2021.